Companies ›Consumer Non Cyclicals ›0841.HK

0841.HK — HKEX Food Retail & Distribution

0841.Hk

HK$0,18

Open in Charts → Attach watcher ⌖

— —

HKD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

105,8M HKD

P/E

—

EV / Rev

—

Div yield

—

Op margin

-12,0 %

ROE

-25,9 %

Net margin

-13,4 %

Debt / equity

1,74

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.

Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryFood Retail & Distribution

ActivityFood & Drug Retailing

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

-25,9 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning 0841.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to 0841.HK. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryFood Retail & Distribution

ActivityFood & Drug Retailing

AI synthesis

GENERATED

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.74, indicating a significant reliance on debt financing. Its liquidity position is weak, with a current ratio of 0.68 and negative net cash after subtracting total debt. The price-to-book ratio of 0.22 suggests the market values the company at a deep discount to its book value, reflecting poor asset performance and financial distress.

Profitability is severely underperforming, with a negative return on equity of -25.91% and a negative return on assets of -7.7%. The company reported a net loss of HKD 130.7 million and an operating loss of HKD 117.3 million, far below the typical performance of the Food Retail & Distribution industry. Gross profit of HKD 81.2 million is minimal relative to revenue of HKD 977.9 million, indicating low margins and operational inefficiencies.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution.

Growth is not evident in the current financial period, with negative operating and free cash flows. The company is not expanding but rather retreating, as indicated by the operating cash outflow of HKD 204.3 million and a free cash outflow of HKD 183.7 million. Capital expenditures of HKD 35.8 million are minimal and do not suggest investment in future growth.

The company faces significant liquidity and solvency risks, with a negative net cash position and a high debt load. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative operating cash flow and high leverage suggest a high probability of financial distress. No dilution sources are identified in the current period, but the company may need to issue shares to address liquidity pressures.

Recent financial filings show a deteriorating financial position, with a net loss and negative cash flows. No recent earnings call transcripts or material events are disclosed, but the financial snapshot indicates a company in distress. The absence of positive operational or strategic developments in the data suggests a lack of near-term turnaround.

Key takeaways

The company is operating at a significant loss with negative returns on equity and assets.
High leverage and weak liquidity position the company at risk of insolvency.
Margins are extremely low, and the company is not generating positive cash flows.
No diversification in business or geographic exposure increases vulnerability to external shocks.
The company is not investing in growth and is likely in a contractionary phase.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

HK$0,18

Market cap

HK$111.1M

Enterprise valueⓘ

HK$932.7M

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

0.2x

P / Tangible bookⓘ

0.2x

Tangible book

HK$504.6M

Net cashⓘ

-HK$821.6M

Current ratioⓘ

0.7

Debt / equityⓘ

1.7

ROAⓘ

-7.7%

ROEⓘ

-25.9%

Cash conversionⓘ

156.0%

CapEx / revenueⓘ

-3.7%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin-12,0 %Bottom quartile

Net Margin-13,4 %Bottom quartile

ROE-25,9 %Bottom quartile

Capex / Rev-3,7 %Below median

D/E1,74Bottom quartile

Cash Conv1,56Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Return On Equity
net_income / total_equity
Price To Book
market_price / (adjusted_book_value / shares_outstanding_diluted)
Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Market Price
input from market-data provider (delayed close or quote-shim mid)
Market Cap
market_price * shares_outstanding_diluted
Ev To Revenue
enterprise_value / revenue

Source documents

0841.HK Market data — financials · 2026-05-26

Ownership & reference

Leadership

Ming Chuan ChuExecutive Chairman of the Board

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

0841.HKCanonical

HKEX · HKD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Leadership

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread